INTERNATIONAL BREWERIES PLC (INTBREW)
Nigerian Stock Exchange · Nigeria · prices in NGN · close of 21 Oct 2026
Key indicators
| Last close | NGN 9.500 |
|---|---|
| 52-week range | 8.350 – 15.950 |
| Return, 1 month / 3 months | −1.6% / −28.1% |
| Return, 1 year / 3 years | −31.3% / +165.4% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 61.8% |
| Worst drawdown (1 year) | -41.4% |
| Average daily value traded | 19.26M NGN |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
International Breweries plc is a Nigerian brewing company that makes and sells beer and malt-based drinks. Its brands include Trophy lager, Hero lager and Budweiser, which it brews under licence, along with non-alcoholic malt beverages. The company serves drinkers across Nigeria through distributors, wholesalers and retailers, and it operates brewing plants in different parts of the country. It is based in Nigeria and is part of the global brewing group AB InBev.
On this site INTERNATIONAL BREWERIES PLC appears as a stock on the Nigerian Stock Exchange (Nigeria), code INTBREW, with prices in Nigerian naira (NGN). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
INTERNATIONAL BREWERIES PLC (INTBREW) trades on the Nigerian Stock Exchange in Nigeria. It last closed at NGN 9.500 on 21 October 2026.
Its price-based Market X-Ray is 31 out of 100 (a weak price profile), ranking 121 of 157 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 31.3% and over the last three months it fell 28.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nigerian Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.9% | ||
| From 52-week high | -39.5% | ||
| Momentum | 10 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -28.1% | ||
| 6-month return | -29.1% | ||
| 12-month return, skipping the last month | -30.2% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 61.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.4% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 19.26M NGN | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −1.6% |
| 3 months | −28.1% |
| 6 months | −29.1% |
| 1 year | −31.3% |
| 3 years | +165.4% |
| 5 years | +151.7% |
Signals
| 50-day / 200-day average | 9.789 / 12.007 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.250 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Sep 2026 | NGN 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nigerian Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.